Impaired elastogenesis and increased degradation of elastic fibers has been implicated in the pathogenesis of pelvic organ prolapse. Loss of the elastogenic organizer, fibulin-5 (FBLN5), leads to pelvic organ prolapse in mice. The objective of this study was to investigate the regulation of FBLN5 after surgical injury of the vaginal wall using the rat as a preclinical animal model. Both endogenous and recombinant FBLN5 were degraded after surgical injury. Estrogen did not alter the dramatic loss of vaginal FBLN5 in the acute phase after injury (12-48 h), but resulted in rescue of the poor recovery of FBLN5 levels in the late phase (7 d) of healing in ovariectomized animals. In contrast with estrogen, the general MMP inhibitor, actinonin, abrogated injury-induced degradation of FBLN5 significantly. Further, actinonin rescued the negative effects of injury on biomechanics, histomorphology, and elastic fibers. Control of excessive matrix degradation by local application of actinonin at the time of surgery may lead to improved elastic fiber regeneration and wound healing, thereby potentially enhancing pelvic floor recovery after reconstructive surgery for prolapse.
. Effect of vaginal wall injury on FBLN5. Nulliparous young rats were either not injured or injured as described in Materials and Methods. Injured rats were treated with hydrogel (HG) alone or HG + FBLN5 (10 µg/ml) (n = 5 in each group). Data represent mean ± SEM. After 48 h, vaginal muscularis was harvested and analyzed for levels of endogenous or recombinant FBLN5. (A) Upper blot was incubated with anti-FBLN5 whereas the lower blot was incubated with anti-His tag antibody to recognize recombinant FBLN5. Fig. 2B ). Likewise, local treatment with vaginal conjugated equine estrogen (CEE) cream before and after simple vaginal wall injury did not alter acute downregulation of FBLN5 after injury (Fig. 2C ). Further, preoperative vaginal CEE did not improve the poor recovery of vaginal FBLN5 in ovariectomized animals. Interestingly, long term recovery of vaginal FBLN5 levels after injury was improved not only with systemic estrogen but also with continuing CEE cream after injury (Fig. 2C ).
Effect of protease inhibitors on FBLN5 content in the vaginal wall.
The failure of estrogen to regulate the acute phase of injury-induced loss of FBLN5 led us to seek an alternate approach in which protease inhibitors could be injected directly at the time of injury. Based on experiments demonstrating that both MMP-7 and serine elastase cleaved FBLN5 in vitro 26 , we tested whether a broad-spectrum MMP inhibitor (actinonin) or the serine protease inhibitor sivelestat could prevent injury-induced loss of FBLN5 in the vaginal wall. Virgin cycling rats were injected with PBS, sivelestat or actinonin directly on both sides of the vaginal wall incision at the time of surgery. Twenty-four hours after injury, animals were sacrificed and matrix protein extracted with urea. Actinonin, but not sivelestat, blocked injury-mediated degradation of FBLN5 ( Fig. 3A ). Since MMP-7, but not MMP-9, degraded fibulin-5 in vitro 26 , we tested whether actinonin was effective in ameliorating MMP-7-mediated proteolysis of fibulin-5 ( Fig. 3B ). In agreement with previous studies, MMP-7 converted 50 kDa rFBLN5 into a 37 kDa fragment ( Fig. 3B ). Actinonin completely blocked MMP-7-induced degradation of FBLN5 ( Fig. 3B ).
Next, we investigated the effect of actinonin on FBLN5 content as a function of time after injury in intact cycling rats (12, 24, 48 hours, and 7 and 14 days after injury). As expected, injury resulted in transient decreases in FBLN5 content until 7 d ( Fig. 4A,B ). Vaginal FBLN5 levels were maintained in animals injected with actinonin ( Fig. 4A,B ). Interestingly, in both groups, FBLN5 levels recovered to suprabasal levels 14 d after injury.
Actinonin alters biomechanical properties of the vaginal wall.
To determine whether actinonin altered biomechanical properties of the injured vaginal wall, stress-strain relationships were conducted on rings of vaginal tissue obtained at the distal vagina from uninjured animals and injured animals treated with PBS or actinonin 7 days post injury ( Fig. 5 ). Maximal stress (an index of tissue strength) was decreased significantly 7 d after injury with PBS. Actinonin rescued this loss of tissue strength. Likewise, stiffness was decreased 7 d after injury in the PBS group relative to uninjured sham animals, and actinonin rescued this loss of stiffness ( Fig. 5B ). Maximal strain, maximal vaginal length, and resting length were similar among treatment groups ( Table 1 ). www.nature.com/scientificreports www.nature.com/scientificreports/ Histomorphology of the vaginal wall after injury. Masson's trichrome staining was used to evaluate the impact of vaginal injury on collagen distribution and histomorphology ( Fig. 6 ). In sham-operated animals, the vaginal wall was comprised of an epithelial layer, multiple rugae, and a dense underlying collagen network. Specifically, collagen staining (blue) in the underlying subepithelial space of the lamina propria was thickened and compact ( Fig. 6a,b ). Although looser than the lamina propria, collagen bundles remained dense and tightly organized in the muscularis ( Fig. 6b ) and inflammatory cells were rare. Consistent with previous reports 25 , a large area of injury persisted seven days after injury in PBS-treated animals ( Fig. 6c ) comprised of numerous inflammatory cells (predominantly macrophages by morphology) and loose collagen fibrils ( Fig. 6d ). Interestingly, the compact subepithelial collagen layer was absent at the interface between epithelium and stroma at the site of injury ( Fig. 6d ). Treatment with actinonin at the time of injury ( Fig. 6e ,f) resulted in (i) a smaller area of injury ( Fig. 6B ), (ii), grossly obvious decrease in the number of infiltrating immune cells, and (iii) restoration of the dense subepithelial collagen layer ( Fig. 6f ).
Significant rescue of injury-induced loss of FBLN5 led us to examine elastic fibers after injury. Hart's staining revealed that elastic fibers were numerous throughout the lamina propria and muscularis in uninjured sham animals. The fibers were long, branched, and extended from the subepithelial layer to the inner muscularis ( Fig. 7a ) covering 13.7% of the total cross sectional area. In PBS-treated animals, the absence of elastic fibers at the site of injury was striking. Small truncated fibers could be seen on high magnification at the periphery of www.nature.com/scientificreports www.nature.com/scientificreports/ the injured area (representing 1.9% of the cross sectional area) ( Fig. 7b,d ). Perhaps the most dramatic effect of actinonin was the appearance of numerous long elastic fibers at the site of injury together with truncated fibers suggesting either regeneration of elastic fibers or decreased degradation of fibers at the injury site ( Fig. 7c,d ).
Discussion
The increased failure rate from reconstructive pelvic surgery for pelvic organ prolapse has resulted in an aggressive search for surgical adjuncts including numerous new materials of allografts, xenografts, and mesh 27 , many of which have proven to be associated with significant complications. We and others have used animal models to evaluate the effects of natural biologics on vaginal wound healing including pre-and post-operative estrogen 19, [23] [24] [25] and mesenchymal stem cells 25 . During these studies, inflammatory infiltrates in the vaginal wall after injury and slow time course of healing were remarkable. Although the epithelium quickly healed and appeared intact, the underlying muscularis and biomechanics of the vaginal wall remained compromised. These findings led us to consider the role of pre-and postoperative local estrogen which has been shown to increase protease inhibitors in the vaginal wall or if protease inhibitors directly could provide an adjunct to surgical wound healing. Although vaginal estrogen has been shown to regulate basal vaginal proteases and protease inhibitors 24 FBLN5: Decreased synthesis vs degradation. We concluded that FBLN5 was degraded in the vaginal wall after injury based on rapid loss of FBLN5 after injury (within 12 h) and rescue by the protease inhibitor actinonin. FBLN5 degradation has been described in other pathological conditions. As reported by Vierkotten, et al., degradation of FBLN5 results in increased risk of age-related macular degeneration, by way of fragmentation of Bruch's membrane 28 . Hirai, et al., indicated that truncated FBLN5, and thattruncated FBLN5 does not promote elastogenesis, and this version of the protein increases with age as full-length FBLN5 decreases 29 . Previously, we found that the serine protease PRSS3 cleaved FBLN5 in vitro 8 . This protease, however, was not expressed in the rat vagina. Our work 26 , together with those Djokic et al. 30 , indicate that MMP-7 and MMP-12 (macrophage elastase) cleave FBLN5 in vitro. These proteases are highly expressed in immune cells with various insults [31] [32] [33] [34] and may mediate injury-induced loss of FBLN5. The inflammatory infiltrate, however, remained prominent 7 days after injury, a time in which FBLN5 is returning to normal levels. It is likely, therefore, that natural protease inhibitors may resolve some transient disruption of FBLN5 in the matrix. Actinonin seems to play a major role in prevention of early degradation. Although identification of the exact protease and its regulation are currently under www.nature.com/scientificreports www.nature.com/scientificreports/ investigation, results reported herein indicate that actinonin blocks MMP-7-induced degradation of FBLN5 in vitro. MMP-7-induced generation of the degradative product in vitro was not observed after vaginal injury most likely due to the presence of numerous other proteases in vivo capable of cleaving the degraded fragment into smaller peptides readily cleared within the wound.
Actinonin, matrix dynamics, and biomechanical properties. Like skin and blood vessels, the vagina
is subjected to continuous stresses acting in multiple directions. The mechanical properties of most connective tissues are dominated by the matrix in which fibrillary collagens and hydrated proteoglycans resist tensile and compressive forces whereas elastic fibers confer both compliance and passive recoil. Histomorphology indicated that actinonin was particularly effective in restoring or preventing disruption of the dense collagen network adjacent to the epithelial basement membrane. The increased maximal stress and stiffness with actinonin is likely due to this remarkable increase in localized collagen content beneath the basement membrane. Further, acute loss of elastic fibers at the site of injury was at least partially rescued by actinonin. Unlike the continuous synthesis and recycling of intracellular proteins, elastic fibers are extremely stable in uninjured resting adult tissues. The unique molecular structure, tissue distribution and longevity of elastic fibers predispose them to accumulate damage in aging dermal, pulmonary and vascular tissues 35 . The pro inflammatory effect of elastin degradative peptides may accelerate the inflammation process and impede wound healing 36 . Pelvic organ prolapse may join the list of aging elastic-fiber related diseases and dysregulation of the balance between synthesis and degradation. Local use of protease inhibitors to prevent limited loss of elastic fibers may increase longevity of pelvic organ support and improve risks of prolapse after vaginal delivery or reconstructive pelvic surgery.
Summary and perspectives.
In summary, we conclude that local injection of the broad-spectrum MMP inhibitor actinonin at the site of injury, but not estrogen, rescues acute loss of vaginal FBLN5 and improves histomorphology and biomechanical properties of the vagina in the short term. Injections were well-tolerated with no overt complications. It should be emphasized that matrix remodeling after injury represents a complex balance between synthesis and degradation. Excessive protease activity has been associated with detrimental effects on rotator cuff injuries 37 , diabetic ulcers 38 , and cancer progression [39] [40] [41] . Additional studies are needed to test the long-term effects of local protease inhibition on vaginal structure, function, and resilience against further injury. This initial work indicates that local protease inhibitors may protect the vagina early in the healing process, a vulnerable time in which patient activity is increasing after surgery.
Methods
All animals were handled and euthanized in accordance with the standards of humane animal care described by the National Institutes of Health Guide for the Care and Use of Laboratory Animals, using protocols approved by the Institutional Animal Care and UseCommittee (IACUC) of the University of Texas Southwestern Medical Center at Dallas. A total of 250 virginal cycling female Sprague Dawley rats (Charles River Laboratories) at 12 weeks of age were housed in IACUC-approved facilities under a 12-L:12-D cycle at 22 °C (104 for estrogen studies and 146 for protease inhibitor experiments) 25 .
Hydrogel and recombinant fibulin-5. The posterior vaginal wall of young (2-4 months of age) Sprague
Dawley rats was injured by creating a posterior wall incision from the introitus to mid-vagina through the epithelium and stroma. Thereafter, the injury site was injected submucosally with HG alone or 1 µg of recombinant FBLN5-containing HG (100 µl of 10 µg/ml) as described previously 21 . Recombinant FBLN5 contained a His tag and could thereby be discerned by His tag antibodies. Further, recombinant FBLN5 is not glycosylated and was differentiated from endogenous FBLN5 by its increased mobility on SDS gels (50 kDa compared with 65 kDa). Animals were anesthetized by isoflurane and monitored every 15 min × 1 h, then daily for adverse reactions. Vaginal tissue was harvested 48 h after injury. Treatment groups. Vaginal injury was created by a posterior wall incision from the introitus to the mid vagina through the epithelium and stroma (Fig. 8) 25 . To optimize the impact of vaginal injury on FBLN5 levels, initial experiments were conducted with two types of vaginal injury using intact cycling rats. In another set of experiments, ovariectomized animals were used to control vaginal estrogen levels. Four conditions were used: systemic estrogen (50 µg/kg × 3 d, then every other day), placebo vaginal cream, preoperative low dose conjugated equine estrogen cream (CEE, 0.625 µg/d), and continuous CEE cream pre-and postoperatively (Supplemental Tissue processing. After euthanasia, the abdominal cavity was opened, the pubic symphysis disarticulated, and the uterine horns, bladder, cervix, and vagina dissected down to the perineal skin. Using microsurgical instruments and a dissection microscope, the perineal skin was removed and the bladder and urethra separated from the anterior vaginal wall. Uterine horns and cervix were removed from the vagina 19, 25, 42 . For animals randomized for histological analysis and biomechanical testing two rings were collected from the distal vagina. The vagina of animals randomized to immunoblotting or hydroxyproline quantification was opened longitudinally Figure) , the epithelium was scraped off with a scalpel, and the posterior one-third collected, snap frozen in liquid nitrogen and stored at −80 °C. Specifically, the injured muscularis was comprised of the site of injury within 5 mm on either side. Matrix protein extraction. Frozen vaginal tissue was pulverized with a liquid nitrogen-chilled mortar and pestle. Tissue powder was then homogenized in basic buffer containing protease inhibitors (PIs) (16 mM potassium phosphate, pH 7.8, 0.12 M NaCl, 1 mM ethylenediaminetetraacetic acid, 0.1 mM phenylmethylsulfonyl fluoride, 10 μg/ml pepstatin A, and 10 μg/ml leupeptin) and centrifuged at 10 000 × g. The supernatant was then removed, and the previous homogenization step repeated after resuspending the remaining tissue pellet in basic buffer. After removal of the second supernatant, the remaining tissue pellet was suspended in 6.0 M urea in the above basic buffer, homogenized, and placed on a rotating rack for overnight extraction at 4 °C. The samples were then centrifuged (10 000 × g for 30 min), and the supernatant removed. Protein concentrations were determined using a bicinchoninic acid protein assay with standard curves of bovine serum albumin in appropriate buffers 19,25,42 . Immunoblot analysis. Urea-extracted protein samples (15 μg/lane) were applied to 4-20% gradient polyacrylamide gels (Bio-Rad), separated by electrophoresis, and transferred to nitrocellulose membranes. Identical gels were run side-by-side and Commassie blue-stained for protein loading comparison among the samples. After protein transfer, membranes were treated with blocking buffer, tris (hydroxymethyl) aminomethane 0.01 M, NaCl 0.15 M, Tween 20, 0.1%, pH 7.4 (TBS-T) with 2.5% nonfat milk for 1 h. Membranes were incubated in primary antibody, rabbit anti-rat FBLN5 (BSYN1923) at 1:250 dilution, overnight at 4 °C and then serially washed with TBS-T, followed by treatment with secondary antibody (goat immunoglobulin G anti-rabbit, 1:8000) at room temperature for 1 h. Membranes were serially washed with TBS-T and subsequently incubated with Western Lightning Chemiluminescence Reagent Plus (Perkin-Elmer) for 2 min. Signal strength was captured using a Fujifilm FLA 5100 image capture system. Protein band density was calculated using Image J software (ImageJ 1.46r, NIH) and normalized to total protein loaded quantified on Coomassie-stained gels 19,25,42 . Biomechanical testing. Biomechanical properties of individual vaginal rings were quantified as previously described 19, 43 . Each vaginal ring was suspended between two stainless steel wire mounts and attached to a steel rod apparatus with a calibrated mechanical drive and to a force transducer. Tissues were maintained in 
